Avara Pharmaceutical Services is a a new CDMO acquiring top performing ex-pharma sites, along with long term supply agreements with the innovator companies. This model allows us to quickly grow while retaining financial stability and superb quality.
Avara currently offers API and Drug Product from four facilites (US/EU) and will soon be announcing additional manufacturing technologies and acquisitions.
“Delivery on time, in full and at a fair price.”
1:30 PM–1:45 PM Jun 7, 2018 (US - Eastern)